International Journal of Cardiology
Volume 137, Issue 2 , Pages 102-107 , October 2009

Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination

Received 5 November 2007 ,Revised 17 March 2008 ,Accepted 28 June 2008.

References 

  1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N
  2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306:1018–1022
  3. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 1995;98:476–484
  4. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol. 1998;32:695–703
  5. Vidaillet H, Granada JF, Chyou PH, et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 2002;113:365–370
  6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–988
  7. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE Rautaharju PM for the CHS Collaborator Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236–241
  8. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med. 1995;155:469–473
  9. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375
  10. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart. 2001;86:284–288
  11. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840–844
  12. Djousse L, Levy D, Benjamin EJ, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham study. Am J Cardiol. 2004;93:710–713
  13. Kubo M, Kiyohara Y, Kato I, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community. The Hisayama Study. Stroke. 2003;34:2349–2354
  14. Miyamatsu N, et al. for the NIPPON DATA80 Research Group Different effects of blood pressure on mortality from stroke subtypes depending on BMI levels: a 19-year cohort study in the Japanese general population — NIPPON DATA80. J Hum Hypertens. 2005;19:285–291
  15. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–2369
  16. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199–206
  17. Sekikawa A, Satoh T, Hayakawa T, Ueshima H, Kuller LH. Coronary heart disease mortality among men aged 35–44 years by prefecture in Japan in 1995–1999 compared with that among white men aged 35–44 by State in the United States in 1995–1998. Vital statistics data in recent birth cohorts. Jpn Circ J. 2001;65:887–892
  18. Yokoyama M, et al. for the Japan EPA Lipid Intervention Study Investigators Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090–1098
  19. GISSI-Prevenzione Investigators (Gruppe Italiano per lo Studio della Sopravvienza nell'infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455
  20. Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H. A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke. 1997;28:45–52
  21. Kitamura A, Shimamoto T, Doi M, et al. Secular trends in prevalence and incidence of atrial fibrillation and associated factors in a Japanese rural population. Jpn J Public Health. 1991;38:98–105(Japanese with English abstract)
  22. Ohsawa M, Okayama A, Sakata K, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980,1990 and 2000. J Epidemiol. 2005;15:194–196
  23. Japanese Registry of Residents in 2005. The Ministry of Internal Affairs and Communications, Japan. Statistics Bureau. (in Japanese) http://www.soumu.go.jp/s-news/2005/050727_3.html
  24. Population Projection for Japan. National Institute of Population and Social Security Research, Japan. (in Japanese) http://www.jpss.go.jp
  25. Lok NS, Lau CP. Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly. Int J Cardiol. 1996;54:231–236
  26. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.. Circulation. 2006;114:119–125
  27. Hurley V, Ireson R, Fletcher K, Lip GYP, Hobbs FDR Mant J on behalf of the BAFTA Investigators. A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial. Int J Cardiol. 2007;117:152–156
  28. Ohsawa M, et al. for the NIPPON DATA80 Research Group Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population — nineteen-year follow-up in NIPPON DATA80 -. Circ J. 2007;71:814–819
  29. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983;106:389–396
  30. Tomita F, et al. for the Hokkaido Atrial Fibrillation Study Group Prevalence and clinical characteristics of patients with atrial fibrillation. Analysis of 20,000 cases in Japan. Jpn Circ J. 2000;64:653–659
  31. The AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002;143:991–1001
  32. Lip GYH, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol. 2005;105:319–321
  33. The Ministry of Health, Labor and Welfare, Japan. Statistical database. (in Japanese) http://www1.mhlw.go.jp/toukei/h10-ktyosa/1-2-9_8.html
  34. Watanabe E, Kuno Y, Takasuga H, et al. Seasonal variation in paroxysmal atrial fibrillation documented by 24-hour Holter electrocardiogram. Heart Rhythm. 2007;4:27–31
  35. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(08)00825-5

doi: 10.1016/j.ijcard.2008.06.029

International Journal of Cardiology
Volume 137, Issue 2 , Pages 102-107 , October 2009

Article Tools